ESMO 2018 Congress

Munich, Germany – 19 Oct – 23 Oct 2018

Myriam Fabre, PhD. (Oncomatryx R&D Director) presents the poster:

OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments

Myriam Fabre1,6, Cristina Ferrer1, Saioa Domínguez-Hormaetxe1, Roland Kontermann2, Klaus Pfizenmaier2, Oliver Seifert2, Pedro P. López-Casas3, Muhammad Abbas4, Wolfgang Richter4, Laureano Simon1, Manuel Hidalgo5.

If you are also attending this event and you would like to meet us please fill this form to arrange an appointment.

[contact-form-7 id=”804″ title=”PRO appointment”]